75/100B47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Sanofi ADS's current ratio is 1.12: current assets of 33.21B EUR against current liabilities of 29.77B EUR due within a year.
- Today
- 1.12
- Average, 5 years
- 1.21
- Low, 5 years
- 0.99
- High, 5 years
- 1.46
Current ratio = current assets ÷ current liabilities = 33.21B ÷ 29.77B = 1.12
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 1.12 | 33.21B | 29.77B | |
| FY2025 | 31 Dec 2025 | 1.09 | 30.95B | 28.35B |
| FY2024 | 31 Dec 2024 | 1.46 | 42.59B | 29.16B |
| FY2023 | 31 Dec 2023 | 1.27 | 30.66B | 24.19B |
| FY2022 | 31 Dec 2022 | 1.42 | 34.03B | 23.96B |
| FY2021 | 31 Dec 2021 | 1.44 | 30.56B | 21.30B |
| FY2020 | 31 Dec 2020 | 1.75 | 33.70B | 19.25B |
| FY2019 | 31 Dec 2019 | 1.40 | 28.61B | 20.38B |
| FY2018 | 31 Dec 2018 | 1.41 | 24.58B | 17.38B |
| FY2017 | 31 Dec 2017 | 1.70 | 26.35B | 15.46B |
| FY2016 | 31 Dec 2016 | 1.62 | 26.69B | 16.43B |
| FY2015 | 31 Dec 2015 | 1.48 | 24.93B | 16.83B |
| FY2014 | 31 Dec 2014 | 1.80 | 23.43B | 13.03B |
| FY2013 | 31 Dec 2013 | 1.72 | 23.91B | 13.93B |
| FY2012 | 31 Dec 2012 | 1.65 | 22.80B | 13.86B |
| FY2011 | 31 Dec 2011 | 1.53 | 20.79B | 13.56B |
| FY2010 | 31 Dec 2010 | 1.99 | 20.04B | 10.09B |
| FY2009 | 31 Dec 2009 | 1.60 | 17.53B | 10.97B |
| FY2008 | 31 Dec 2008 | 1.65 | 15.40B | 9.35B |
| FY2007 | 31 Dec 2007 | 1.30 | 12.55B | 9.67B |
| FY2006 | 31 Dec 2006 | 1.18 | 12.16B | 10.28B |
| FY2005 | 31 Dec 2005 | 0.85 | 13.12B | 15.42B |
| FY2004 | 31 Dec 2004 | 0.79 | 11.96B | 15.18B |
| FY2003 | 31 Dec 2003 | 2.71 | 7.02B | 2.59B |
| FY2002 | 31 Dec 2002 | 2.58 | 6.57B | 2.55B |
| FY2001 | 31 Dec 2001 | 2.55 | 7.67B | 3.01B |
| FY2000 | 31 Dec 2000 | 2.56 | 5.80B | 2.26B |
| FY1999 | 31 Dec 1999 | 2.09 | 4.64B | 2.22B |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.12 | 33.21B | 29.77B |
| Q2 FY2026 | 30 Jun 2026 | 0.99 | 31.52B | 31.93B |
| Q1 FY2026 | 31 Mar 2026 | 1.01 | 30.16B | 30.01B |
| Q4 FY2025 | 31 Dec 2025 | 1.09 | 30.95B | 28.35B |
| Q3 FY2025 | 30 Sept 2025 | 1.06 | 34.04B | 32.11B |
| Q2 FY2025 | 30 Jun 2025 | 1.27 | 37.02B | 29.06B |
| Q1 FY2025 | 31 Mar 2025 | 1.37 | 44.02B | 32.22B |
| Q4 FY2024 | 31 Dec 2024 | 1.46 | 42.59B | 29.16B |
| Q3 FY2024 | 30 Sept 2024 | — | — | — |
| Q2 FY2024 | 30 Jun 2024 | 1.00 | 30.08B | 30.03B |
| Q1 FY2024 | 31 Mar 2024 | — | 8.71B | 0.00 |
| Q4 FY2023 | 31 Dec 2023 | 1.27 | 30.66B | 24.19B |
| Q3 FY2023 | 30 Sept 2023 | — | 7.99B | 0.00 |
| Q2 FY2023 | 30 Jun 2023 | 1.21 | 29.98B | 24.76B |
| Q1 FY2023 | 31 Mar 2023 | — | 12.74B | 0.00 |
| Q4 FY2022 | 31 Dec 2022 | 1.42 | 34.03B | 23.96B |
| Q3 FY2022 | 30 Sept 2022 | — | 6.90B | 0.00 |
| Q2 FY2022 | 30 Jun 2022 | 1.29 | 28.36B | 22.06B |
| Q1 FY2022 | 31 Mar 2022 | — | 10.11B | 0.00 |
| Q4 FY2021 | 31 Dec 2021 | 1.44 | 30.56B | 21.30B |
| Q3 FY2021 | 30 Sept 2021 | — | 9.72B | 0.00 |
| Q2 FY2021 | 30 Jun 2021 | 1.54 | 29.50B | 19.13B |
| Q1 FY2021 | 31 Mar 2021 | — | 13.92B | 0.00 |
| Q4 FY2020 | 31 Dec 2020 | 1.75 | 33.70B | 19.25B |
| Q3 FY2020 | 30 Sept 2020 | — | 0.00 | 0.00 |
| Q2 FY2020 | 30 Jun 2020 | 1.85 | 34.79B | 18.80B |
| Q1 FY2020 | 31 Mar 2020 | — | 0.00 | 0.00 |
| Q4 FY2019 | 31 Dec 2019 | 1.40 | 28.61B | 20.38B |
| Q3 FY2019 | 30 Sept 2019 | — | 6.74B | 0.00 |
| Q2 FY2019 | 30 Jun 2019 | 1.32 | 25.31B | 19.21B |
| Q1 FY2019 | 31 Mar 2019 | — | 6.96B | 0.00 |
| Q4 FY2018 | 31 Dec 2018 | 1.41 | 24.58B | 17.38B |
| Q3 FY2018 | 30 Sept 2018 | — | 7.49B | 0.00 |
| Q2 FY2018 | 30 Jun 2018 | 1.22 | 23.94B | 19.61B |
| Q1 FY2018 | 31 Mar 2018 | 1.58 | 29.77B | 18.84B |
| Q4 FY2017 | 31 Dec 2017 | 1.70 | 26.35B | 15.46B |
| Q3 FY2017 | 30 Sept 2017 | — | 10.88B | 0.00 |
| Q2 FY2017 | 30 Jun 2017 | 1.59 | 27.07B | 17.06B |
| Q1 FY2017 | 31 Mar 2017 | — | 10.31B | 0.00 |
| Q4 FY2016 | 31 Dec 2016 | 1.62 | 26.69B | 16.43B |
| Q3 FY2016 | 30 Sept 2016 | — | 6.21B | 0.00 |
| Q2 FY2016 | 30 Jun 2016 | 1.75 | 28.35B | 16.22B |
| Q1 FY2016 | 31 Mar 2016 | — | 9.20B | 0.00 |
| Q4 FY2015 | 31 Dec 2015 | 1.48 | 24.93B | 16.83B |
| Q3 FY2015 | 30 Sept 2015 | — | 4.93B | 0.00 |
| Q2 FY2015 | 30 Jun 2015 | 1.35 | 22.03B | 16.30B |
| Q1 FY2015 | 31 Mar 2015 | — | 7.45B | 0.00 |
| Q4 FY2014 | 31 Dec 2014 | 1.80 | 23.43B | 13.03B |
| Q3 FY2014 | 30 Sept 2014 | — | 4.37B | 0.00 |
| Q2 FY2014 | 30 Jun 2014 | 1.44 | 20.39B | 14.20B |
| Q1 FY2014 | 31 Mar 2014 | — | 8.34B | 0.00 |
| Q4 FY2013 | 31 Dec 2013 | 1.72 | 23.91B | 13.93B |
| Q3 FY2013 | 30 Sept 2013 | — | 4.26B | 0.00 |
| Q2 FY2013 | 30 Jun 2013 | 1.53 | 20.86B | 13.64B |
| Q1 FY2013 | 31 Mar 2013 | — | 6.48B | 0.00 |
| Q4 FY2012 | 31 Dec 2012 | 1.65 | 22.80B | 13.86B |
| Q3 FY2012 | 30 Sept 2012 | — | — | — |
| Q2 FY2012 | 30 Jun 2012 | 1.33 | 21.45B | 16.07B |
| Q1 FY2012 | 31 Mar 2012 | — | — | — |
| Q4 FY2011 | 31 Dec 2011 | 1.54 | 20.86B | 13.58B |
| Q3 FY2011 | 30 Sept 2011 | — | — | — |
| Q2 FY2011 | 30 Jun 2011 | 1.41 | 22.59B | 16.04B |
| Q1 FY2011 | 31 Mar 2011 | — | — | — |
| Q4 FY2010 | 31 Dec 2010 | 2.30 | 27.08B | 11.76B |
| Q3 FY2010 | 30 Sept 2010 | — | — | — |
| Q2 FY2010 | 30 Jun 2010 | 1.68 | 17.49B | 10.43B |
| Q1 FY2010 | 31 Mar 2010 | — | — | — |
| Q4 FY2009 | 31 Dec 2009 | 1.60 | 17.53B | 10.97B |
| Q3 FY2009 | 30 Sept 2009 | — | — | — |
| Q2 FY2009 | 30 Jun 2009 | 1.72 | 18.53B | 10.79B |
| Q1 FY2009 | 31 Mar 2009 | — | — | — |
| Q4 FY2008 | 31 Dec 2008 | 1.65 | 15.40B | 9.35B |
| Q3 FY2008 | 30 Sept 2008 | — | — | — |
| Q2 FY2008 | 30 Jun 2008 | 1.33 | 11.92B | 8.97B |
| Q1 FY2008 | 31 Mar 2008 | — | — | — |
| Q4 FY2007 | 31 Dec 2007 | 1.30 | 12.55B | 9.67B |
| Q3 FY2007 | 30 Sept 2007 | — | — | — |
| Q2 FY2007 | 30 Jun 2007 | 1.27 | 12.42B | 9.78B |
| Q1 FY2007 | 31 Mar 2007 | — | — | — |
| Q4 FY2006 | 31 Dec 2006 | 1.18 | 12.16B | 10.28B |
| Q3 FY2006 | 30 Sept 2006 | — | — | — |
| Q2 FY2006 | 30 Jun 2006 | 0.86 | 12.30B | 14.25B |
| Q1 FY2006 | 31 Mar 2006 | — | — | — |
| Q4 FY2005 | 31 Dec 2005 | 0.85 | 13.11B | 15.41B |
| Q3 FY2005 | 30 Sept 2005 | — | — | — |
| Q2 FY2005 | 30 Jun 2005 | 0.81 | 13.10B | 16.25B |
| Q1 FY2005 | 31 Mar 2005 | — | — | — |
| Q4 FY2004 | 31 Dec 2004 | 0.79 | 11.95B | 15.17B |
| Q3 FY2004 | 30 Sept 2004 | — | — | — |
| Q2 FY2004 | 30 Jun 2004 | 2.62 | 7.47B | 2.85B |
| Q1 FY2004 | 31 Mar 2004 | — | — | — |
| Q4 FY2003 | 31 Dec 2003 | 2.71 | 7.02B | 2.59B |
| Q3 FY2003 | 30 Sept 2003 | — | — | — |
| Q2 FY2003 | 30 Jun 2003 | 2.52 | 6.01B | 2.38B |
| Q1 FY2003 | 31 Mar 2003 | — | — | — |
| Q4 FY2002 | 31 Dec 2002 | 2.58 | 6.57B | 2.55B |
| Q3 FY2002 | 30 Sept 2002 | — | — | — |
| Q2 FY2002 | 30 Jun 2002 | 2.47 | 6.54B | 2.65B |
Figures in EUR. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Debt to equity,All ratios
Common questions about Sanofi ADS's current ratio
Source: Financial Modeling Prep